Trial Profile
Nonmyeloablative Hematopoietic Cell Transplantation for Patients With Fanconi Anemia Using Alternative Marrow Donors: A Phase II Dose-Finding Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Ciclosporin; Ciclosporin; Mycophenolate mofetil
- Indications Fanconi's anaemia; Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 17 Jan 2020 Status changed from active, no longer recruiting to completed.
- 08 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
- 17 Dec 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.